Angio-Seal in Antegrade Endovascular Interventions: Technical Success and Complications in a 55-Patient Series

Abstract

Purpose:

To assess the technical success and complications of Angio-Seal vascular closure device in antegrade common femoral artery (CFA) punctures.

Methods:

Over a 14-month period, 55 patients (37 men; age range 37–94 years) underwent antegrade CFA Angio-Seal placement at a single center; the clinical data and angiograms were reviewed retrospectively. A total of 56 antegrade CFA punctures were made for hemostasis; 6-F Angio-Seal devices (40 model STS and 12 model VIP) were deployed in 52 CFAs, and 8-F Angio-Seal devices were deployed in 4.

Results:

The technical success rate was 98.2% (55/56). Two (3.6%) patients developed small, non-expanding hematomas (<5 cm) during deployment of the device. There was 1 episode of device/operator failure, presumably due to extravascular deployment within soft tissue. None of the patients developed pseudoaneurysm, arterial injury, or large hematomas requiring transfusion. Small calcified plaques at the puncture site did not influence the outcome.

Conclusion:

This series suggests that Angio-Seal may be a safe and effective device for hemostasis in antegrade CFA punctures. Further randomized trials testing its risk-benefit balance in comparison to standard manual compression are warranted.

Keywords

vascular access vascular closure device common femoral artery hemostasis outcome analysis

Get full access to this article

View all access options for this article.

References

Ricci

Trevisani

Pilcher

. Vascular complications of cardiac catheterization. Am J Surg. 1994; 167: 375–378.

Eidt

Habibipour

Saucedo

. Surgical complications from hemostatic puncture closure devices. Am J Surg. 1999; 178: 511–516.

Aksoy

Becquemin

J-P

Desgranges

. The safety and efficacy of Angioseal in therapeutic endovascular interventions. Eur J Vasc Endovasc Surg. 2006; 32: 90–93.

Semler

. Transfemoral catheterization: Mechanical versus manual control of bleeding. Radiology. 1985; 154: 234–235.

Prayck

Wall

Longabaugh

. A randomized trial of vascular hemostasis techniques to reduce femoral vascular complications after coronary intervention. Am J Cardiol. 1998; 81: 970–976.

Michalis

Rees

Patsouras

. A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angioseal, Vasoseal and Duett). Cardiovasc Intervent Radiol. 2002; 25: 423–429.

Abando

Hood

Weaver

. The use of the Angioseal device for femoral artery closure. J Vasc Surg. 2004; 40: 287–290.

Vaitkus

. A metaanlysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention. J Invasive Cardiol. 2004; 16: 243–246.

Bos

Hunink

Mali

. Use of a collagen hemostatic closure device to achieve hemostasis after arterial puncture: A cost effective analysis. J Vasc Interv Radiol. 1996; 7: 479–486.

10.

Silber

Tofte

Kjellevand

. Report of the European multicentre registry using the Duett vascular sealing device. Hertz. 1999; 24: 620–623.

11.

Silber

. 10 years of arterial closure devices: A critical analysis of their use after PTCA. Z Kardiol. 2000; 89: 383–389.

12.

Mukhopadhyay

Puckett

Roobottom

. Efficacy and complications of Angioseal in antegrade puncture. Eur J Radiol. 2005; 56: 409–412.

13.

Kirchhof

Schickel

Schmidt-Lucke

. Local vascular complications after use of the hemostatic puncture closure device Angioseal. Vasa. 2002; 31: 101–106.

14.

Carey

Martin

Moore

. Complications of femoral artery closure devices. Catheter Cardiovasc Interv. 2001; 52: 3–7.

15.

Wille

Vos

Overtoom

. Acute leg ischemia: The dark side of a percutaneous femoral closure device. Ann Vasc Surg. 2006; 20: 278–281.

16.

Shaw

Gravereaux

Winters

. An unusual cause of claudication. Catheter Cardiovasc Interv. 2003; 60: 562–565.